Operating Lease, Right-of-Use Asset in USD of Nurix Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nurix Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2020 to Q3 2025.
  • Nurix Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Aug 2025 was $53M, a 95.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $53M +$25.9M +95.8% 31 Aug 2025 10-Q 09 Oct 2025
Q2 2025 $50.2M +$21.4M +74.1% 31 May 2025 10-Q 09 Jul 2025
Q1 2025 $26.4M -$2.94M -10% 28 Feb 2025 10-Q 08 Apr 2025
Q4 2024 $28.1M -$3M -9.64% 30 Nov 2024 10-Q 09 Oct 2025
Q3 2024 $27.1M +$18.1M +200% 31 Aug 2024 10-Q 11 Oct 2024
Q2 2024 $28.8M +$18.9M +190% 31 May 2024 10-Q 11 Jul 2024
Q1 2024 $29.3M +$18.4M +168% 29 Feb 2024 10-Q 10 Apr 2024
Q4 2023 $31.1M +$18.8M +152% 30 Nov 2023 10-K 28 Jan 2025
Q3 2023 $9.03M -$4.82M -34.8% 31 Aug 2023 10-Q 12 Oct 2023
Q2 2023 $9.94M -$5.48M -35.5% 31 May 2023 10-Q 13 Jul 2023
Q1 2023 $10.9M -$4.96M -31.2% 28 Feb 2023 10-Q 13 Apr 2023
Q4 2022 $12.3M -$1.66M -11.9% 30 Nov 2022 10-K 15 Feb 2024
Q3 2022 $13.8M 31 Aug 2022 10-Q 06 Oct 2022
Q2 2022 $15.4M 31 May 2022 10-Q 07 Jul 2022
Q1 2022 $15.9M 28 Feb 2022 10-Q 08 Apr 2022
Q4 2021 $14M +$662K +4.96% 30 Nov 2021 10-K 09 Feb 2023
Q4 2020 $13.3M 01 Dec 2020 10-Q 06 Oct 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.